In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- American Pharoah to Haskell
- Force Upsets New York Derby
- Oaklawn Improvements Include New Barn
- Filly First Winner for Here Comes Ben
- Two Share Record Price at Arqana Summer Sale
- Catalog Online for Barretts Select Sale
- Pedigree Analysis: Olympia
- Laurel Cancels Racing Due to Water Main Break
- 'Evolution of Racing' Approaches in Lexington
- Main Sequence Class of Loaded United Nations